El aseguramiento del daño en la Ley 14/2007, de Investigación Biomédica

Referencias bibliográficas

• EMANUEL, E. / WENDLER, D. / Grady, C (2000), ‘What makes clinical research ethical?’, JAMA, Vol. 283, 2000, pp. 2701-11.
• RAMIRO AVILÉS, M.A., ‘Los participantes indirectos en los ensayo clínicos’, Medicina Clínica, Núm. 5, Vol. 135, 2010, pp. 231-5.
• HENRY, L.M., “Moral Gridlock: Conceptual barriers to no-fault compensation for injured research subjects”, Journal of Law, Medicine & Ethics, Núm. 2, Vol. 41, 2013, pp. 411-23,
• RAMIRO AVILÉS, M.A., “Compensation of research-related injuries in the European Union”, European Journal of Health Law, Núm. 4, Vol. 21, 2014, pp. 473-87.
• RAMIRO AVILÉS, M.A., “Paving the road to negligence: the compensation of research-related injuries in Spain”, Accountability in Research, Núm. 2, Vol. 22, 2015, pp. 106-19.
• SPRUMONT, D. / GYTIS, A., “The importance of national laws in the implementation of european legislation of biomedical research”, European Journal of Health Law, Núm. 11, 2005, pp. 245-267.
• ELLIOT, C. “Justice for Injured Research Subjects”, New England Journal of Medicine, Vol. 367, 2012, pp. 6-8;
• HENRY, L.M., “Moral Gridlock: Conceptual barriers to no-fault compensation for injured research subjects”, Journal of Law, Medicine & Ethics, Núm. 2, Vol. 41, 2013, pp. 411-23;
• LARKIN, M.E., “Defining compensable injury in biomedical research”, Health Matrix, Vol. 25, 2015, pp. 309-82
• REVERBY, S. “Normal exposure and inoculation of syphilis: A PHS ‘Tuskegee’ doctor in Guatemala, 1946-1948”, The Journal of Policy History, Núm. 1, Vol. 23, 2011, pp. 6-28.
• BEH, H., “Compensation for research injuries”, IRB: Ethics & Human Research, Núm. 3, Vol. 27, 2005, pp. 11-5;
• RESNIK, D.B., “Compensation for research-related injuries”, The Journal of Legal Medicine, Vol. 2, 2006, pp. 263-87;
• SCOTT, L.D. “Re-search-related injury: problems and solutions”, Journal of Law, Medicine & Ethics, Núm. 31, 2003, pp. 419-28;
• STEINBROOK, R., “Compensation for injured research subjects”, New England Journal of Medicine, Vol. 354, 2006, pp. 1871-3;
• LARKIN, M.E., “Defining compensable injury in biomedical research”, Health Matrix, Vol. 25, 2015, pp. 309-82; PIKE, E.R., “Recovering from research: A no-fault proposal to compensate injured research participants”, American Journal of Law & Medicine, Vol. 38, 2012, pp. 7-62
• ANSUATEGUI ROIG, F.J., “Derechos humanos y ensayos clínicos”, Derechos y Libertades, Núm. 7, 1999, pp. 115-30;
• SAIZ GARCÍA, C., “Responsabilidad médicosanitaria derivada de los experimentos clínicos en humanos”, La salud: intimidad y libertades informativas, Ed. Tirant lo Blanch, Valencia, España. 2006, pp. 127-67;
• JIMÉNEZ-ASENJO, L., “El seguro obligatorio de ensayos clínicos: riesgos, límites y cláusulas de exclusión (I)”, Actualidad de Derecho Sanitario, Vol. 139, 2007, pp. 447-53;
• JIMÉNEZ-ASENJO, L., “El seguro obligatorio de ensayos clínicos: riesgos, límites y cláusulas de exclusión (II)”, Actualidad de Derecho Sanitario, Vol. 140, 2007, pp. 570-7;
• DE ABAJO, F.J. / RODRÍGUEZ, A. / BLAS, J., “El seguro de responsabilidad civil en los ensayos clínicos: Reflexiones a propósito de una reclamación”, Medicina Clínica, Vol. 140, 2013, pp. 224-8.
• CHILDRESS, J., “Compensating injured research subjects: I. The moral argument”, The Hastings Center Report, Vol. 6, 1976, pp. 21-7.
• LARKIN, M.E., “Defining compensable injury in biomedical research”, Health Matrix, Vol. 25, 2015, p. 344
• FOLKERS G.K. / FAUCI, A., “The AIDS research model: Implications for other infectious diseases of global health importance”, JAMA, Vol. 286, 2001, pp. 458-61.
• PALELLA F.J. et ál., “Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection”, New England Journal of Medicine, Vol. 338, 1998, pp. 853-60;
• VAN SIGHEM AI. et ál., “Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals”, Aids, Vol. 24, 2010, pp. 1527-35;
• LLIBRE, J.M. et ál., “The changing face of HIV/AIDS in treated patients”, Current HIV Research, Núm. 4, Vol. 7, 2009, pp. 365-77.
• KVISTAD, C.E. / KHANEVSKI, A. / NACU, A. / THOMASSEN, L. / WAJE-ANDREASSEN, U. / NAESS, H., “Is higher body temperature beneficial in ischemic stroke patients with normal admission cT angiography of the cerebral arteries?”, Vascular Health and Risk Management, Vol. 10, 2014, pp. 49-54
• KVISTAD, C.E. / THOMASSEN, L. / WAJE-ANDREASSEN, U. / NAESS, H., “Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study”, Vascular Health and Risk Management, Vol. 8, 2012, pp. 333-8.
• WENDLER, D.S., The Ethics of Pediatric Research, Oxford University Press, Nueva York, Estados Unidos de América, 2010.
• CHILDRESS, J., “Compensating injured research subjects: I. The moral argument”, The Hastings Center Report, Vol. 6, 1976, pp. 21-7.
• ARRIETA, J., “Evaluación económica del tratamiento sustitutivo renal (hemodiálisis, diálisis peritoneal y trasplante) en España”, Nefrología 1 (Supl Ext 1), 2010, pp. 37-47.
• MENIKOFF J., “The vulnerability of the very sick”, Journal of Law, Medicine & Ethics, Núm. 1, Vol. 37, 2009, pp. 51-8.
• PAASCHE-ORLOW, M.K. / Brancati, F.L. “Assessment of medical school institutional review board policies regarding compensation of subjects for research-related injury”, The American Journal of Medicine, Vol. 118, 2005, pp. 175-80.
• PAASCHEORLOW, M.K. / TAYLOR, M.K. / BRANCATI, F.L., “Readability standards for informed-consent forms a compared with actual readability”, New England Journal of Medicine, Vol. 348, 2003, pp. 721-6.
• COLEMAN, C.H., “Duties to subjects in clinical research”, Vanderbilt Law Review, No. 2, Vol. 58, 2005, p. 419.
• ATIENZA, M., Bioética, Derecho y Argumentación, Temis, Bogotá, Colombia, 2004.
• WERTHEIMER, A., Rethinking the ethics of clinical research: Widening the lens, Oxford University Press, Nueva York, Estados Unidos de América, 12, 2010.
• GONZÁLEZRIVAS, D. / PARADELA, M. / FERNÁNDEZ, R. / DELGADO, M. / FIEIRA, E. / MÉNDEZ, L. / VELASCO, C. / DE LA TORRE, M., “Uniportal video-assisted thoracoscopic lobectomy: Two years of experience”, The Annals of Thoracic Surgery, Núm.2, Vol. 95, 2013, pp. 426-32.
• MIRALLAS-MARTÍNEZ, J.A., “Efectividad de la terapia manual (manipulaciones y movilizaciones) en el dolor cervical inespecífico”, Rehabilitación, Núm. 2, Vol. 41, 2007, pp. 81-7.
• GEORGE, A.T.J. et ál., “When should placebo surgery as a control in clinical trials be carried out?”, The Bulletin of The Royal College of Surgeons of England, Núm. 2, Vol. 98, 2016, pp. 75-9)
• WIGGINS, O.P. et ál (2004) ‘On the ethics of facial transplantation research, American Journal of Bioethics, Núm. 3, Vol. 4, 2004, pp. 1-12);
• KOEPSELL, D. / BRINKMAN, W.P. / PONT, S. “Human Participants in Engineering Research: Notes from a Fledgling Ethics Committee”, Science and Engineering Ethics, Vol. 21, 2015, pp. 1033-48
• KOPELMAN, L.M., “Minimal risk as an international ethical standard”, Journal of Medicine and Philosophy, Núm. 3, Vol. 29, 2004, pp. 351-78;
• GAINOTTI, S. / PETRINI, C., “Insurance policies for clinical trials in the United States and in some European countries”, Journal of Clinical Research and Bioethics, Núm. 1, Vol.1, 2010, doi:10.4172/2155-9627.1000101;
• AVENDAÑO SOLÁ, C., “Cambios en la normativa europea de ensayos clínicos (II): Por una regulación proporcionada y adaptada al riesgo”, Medicina Clínica, Vol. 138, 2012, pp. 574-8.
• RESNIK, D.B., “Compensation for research-related injuries”, The Journal of Legal Medicine, Vol. 27, 2006, 2006, pp. 263-87.
• MARRIMER, W.K., “Compensation for Research Injuries”, Women and Health Research. Ethical and Legal Issues of Including Women in Clinical Studies, Vol. 2, MASTROIANI, A.C. / FADEN, R. / FEDERMAN, D. (Eds.), National Academy, Washington, Estados Unidos de América, 1994, pp. 113-26.